Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients

Fig. 2

Suggested clinical use and scoring of the BladMetrix test. The BladMetrix test, which is an 8-biomarker panel, is scored negative, positive or inconclusive depending on the number of methylated biomarkers. A negative test will spare the patient for a clinical intervention, while both a positive and an inconclusive test will require the patient to undergo cystoscopy, which is in line with todays’ standard routine. Figure created with BioRender.com

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us